Hairy Cell Leukemia

Download PDF

Recent Publications on Hairy Cell Leukemia:
Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. OBJECTIVE: To study the effectiveness of peripheral blood (PB) and bone...	11th July, 2008	Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.	Mayo Clin Proc. 2008 Jul;83(7):776-85.
Review: isolated skeletal involvement in hairy cell leukemia. The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem...	9th July, 2008	Department of Hematology and Oncology, Arthur G. James Comprehensive	Clin Adv Hematol Oncol. 2008 Apr;6(4):294-6.
Localized bone disease as a presentation of hairy cell leukemia. The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem...	9th July, 2008	Rush University Medical Center,	Clin Adv Hematol Oncol. 2008 Apr;6(4):290-4.
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). OBJECTIVE: To study the effectiveness of peripheral blood (PB) and bone...	8th July, 2008	Inselspital Bern.	Haematologica. 2008 Jul 4;. DOI Direct Link
Soluble CD22 as a tumor marker for hairy cell leukemia. CD22 is an important immunotherapeutic target on B-cell malignancies,...	4th July, 2008	Laboratory of Molecular Biology, NCI, Bethesda, MD, United States.	Blood. 2008 Jul 2;. DOI Direct Link
→View more research publications.

Hairy Cell Leukemia Clinical Trials:
A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia	Hairy Cell Leukemia
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation	Cancer Interventions: Procedure: allogeneic bone marrow transplantation;   Procedure: graft versus host disease prophylaxis/therapy
PS-341 in Treating Patients With Advanced Cancer	Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Unspecified Adult Solid Tumor, Protocol Specific
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss	Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer	Leukemia;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
→View more trials.

Hairy Cell Leukemia Patents:
US Patent No.	Title
7371827	Antibodies against the PRO1126 polypeptide
7378502	PRO4389 antibodies
7381720	Substituted quinobenzoxazine analogs
7381722	Tetracyclic amino and carboxamido compounds and methods of use thereof
7381791	PRO9739 polypeptides
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hairy Cell Leukemia scientists - we have details of around 331 individuals working on Hairy Cell Leukemia .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.